Alizee Lebeau
Overview
Explore the profile of Alizee Lebeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pilard C, Roncarati P, Ancion M, Luyckx M, Renard M, Reynders C, et al.
J Immunother Cancer
. 2025 Mar;
13(3).
PMID: 40081943
Background: Originally identified for its involvement in bone remodeling, accumulating data emerged in the past years indicating that receptor activator of nuclear factor κB ligand (RANKL) actually acts as a...
2.
Gucciardo F, Lebeau A, Pirson S, Buntinx F, Ivanova E, Blacher S, et al.
Circulation
. 2025 Mar;
PMID: 40035133
Background: Lymphedema is an incurable disease associated with lymphatic dysfunction that causes tissue swelling and fibrosis. We investigated whether lymphedema could be attenuated by interfering with uPARAP (urokinase plasminogen activator...
3.
Pirson S, Gautier-Isola M, Baudin L, Rouaud L, Vanwynsberghe A, Deroye J, et al.
Cell Mol Life Sci
. 2025 Feb;
82(1):95.
PMID: 40011241
Lymphangiogenesis has gained considerable interest due to its established role in cancer progression and dissemination of metastatic cells through lymph nodes. Deciphering the molecular mechanisms that govern lymphangiogenesis within lymph...
4.
Salmon A, Lebeau A, Streel S, Dheur A, Schoenen S, Goffin F, et al.
Cancer Treat Rev
. 2024 Jul;
129:102790.
PMID: 38972136
Until recently, patients diagnosed with locally advanced and metastatic endometrial cancer faced significant challenges in their treatment due to limited options and poor prognostic outcomes. The sequencing of tumors has...
5.
Schmitz L, Pirotte M, Lebeau A, Ernst M, Fillet M, Devey A, et al.
Ther Adv Hematol
. 2023 Oct;
14:20406207231199837.
PMID: 37780945
Background: For more than 2 years medical practice has been dealing with the Covid-19 pandemic. Atypical symptoms, such as frostbites and acrosyndromes, have appeared, and autoimmune anemias (some of which...
6.
Bruyere D, Roncarati P, Lebeau A, Lerho T, Poulain F, Hendrick E, et al.
Theranostics
. 2023 Feb;
13(3):1130-1149.
PMID: 36793865
Whatever the mucosa primary infected, HPV-positive cancers are traditionally associated with a favorable outcome, attributable to a high sensitivity to radiation therapy. However, the direct impact of viral E6/E7 oncoproteins...
7.
Gillot L, Lebeau A, Baudin L, Pottier C, Louis T, Durre T, et al.
Cell Mol Life Sci
. 2022 May;
79(6):295.
PMID: 35567669
Although lymph node (LN) metastasis is an important prognostic parameter in cervical cancer, the tissue remodeling at a pre-metastatic state is poorly documented in LNs. We here identified periostin (POSTN)...
8.
Gucciardo F, Pirson S, Baudin L, Lebeau A, Noel A
Cell Mol Life Sci
. 2022 Apr;
79(5):255.
PMID: 35460056
The urokinase plasminogen activator receptor-associated protein (uPARAP/Endo180) is already known to be a key collagen receptor involved in collagen internalization and degradation in mesenchymal cells and some macrophages. It is...
9.
Lebeau A, Bruyere D, Roncarati P, Peixoto P, Hervouet E, Cobraiville G, et al.
Nat Commun
. 2022 Mar;
13(1):1076.
PMID: 35228537
Despite the high prevalence of both cervico-vaginal human papillomavirus (HPV) infection and bacterial vaginosis (BV) worldwide, their causal relationship remains unclear. While BV has been presumed to be a risk...
10.
Wuidar V, Gillot L, Dias Da Silva I, Lebeau A, Gallez A, Pequeux C
Adv Exp Med Biol
. 2021 Oct;
1329:499-533.
PMID: 34664253
Cancers are heterogeneous multifactorial diseases consisting of a major public health issue worldwide. Sex disparities are evidenced in cancer incidence, mortality, expression of prognosis factor, response to treatment, and survival....